Bharat Biotech

Bhubaneswar: The founder and chairman of Bharat Biotech Krishna Ella visited Bhubaneswar on Wednesday and informed that the Covid-19 vaccine production will start in Odisha by June 2022. The vaccine production unit will be set up on the…
Read More...

New Delhi: Bharat Biotech concluded the final analysis of its Covid-19 vaccine Covaxin and announced the safety and efficacy analysis data from Phase 3 clinical trials on Saturday. According to the analysis, Covaxin has been found to be…
Read More...

New Delhi: Bharat Biotech’s Covaxin is 77.8 per cent effective in the Phase III trials against the novel coronavirus, according to The Drug Controller General of India (DCGI). The Drug Controller General of India (DCGI) held a review…
Read More...

New Delhi: Amid concerns over the effectiveness of Covid vaccines, the Hyderabad-based Bharat Biotech has submitted phase III trial data of Covaxin to Drugs Controller General of India (DCGI). Phase-III trial data is also required for…
Read More...

Hyderabad: Bharat Biotech may commence pediatric trials of its Covid-19 vaccine Covaxin from June, a senior company official said. The vaccine maker has already received permission to carry out trials on children aged 2-18 years.…
Read More...

New-Delhi: The Drug Controller General of India (DGCI) on Thursday gave permission to Bharat Biotech to conduct clinical trials of its Covid-19 vaccines Covaxin on children belonging to the age group of 2 to 18 years. Bharat Biotech will…
Read More...

New Delhi:There is no stock of  Covaxin for those between 18-45 of age and around 100 newly setup vaccination centers at government schools will administer Covishield only. The Kejriwal administration said, as of now, there is no idea…
Read More...

New Delhi: Bharat Biotech's Covid-19 vaccine Covaxin got approved by an expert panel on Tuesday for phase II and III human clinical trials on those between 2-18 years of age. The Subject Expert Committee (SEC) on Covid-19 of the Central…
Read More...

Hyderabad: Bharat Biotech has started direct supplies of its Covid-19 vaccine Covaxin to 14 states. The states are Andhra Pradesh, Assam, Chhattisgarh, Delhi, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Maharashtra, Odisha,…
Read More...

New Delhi: The Indian biotechnology company Bharat Biotech has started its direct supply of Covid-19 vaccine ‘Covaxin’ to 14 states from May 1, according to the company's co-founder and Joint Managing Director Suchitra Ella. The supply…
Read More...